Cubist Systematic Strategies, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$286,408
-82.8%
160,004
-67.3%
0.00%
-80.0%
Q4 2022$1,666,034
+245.7%
490,010
+454.5%
0.01%
+233.3%
Q3 2022$482,000
-43.9%
88,364
-53.6%
0.00%
-40.0%
Q2 2022$859,000
-27.8%
190,479
+18.0%
0.01%
-50.0%
Q1 2022$1,190,000
-67.2%
161,483
-71.3%
0.01%
-70.6%
Q4 2021$3,623,000
+548.1%
563,530
+487.0%
0.03%
+385.7%
Q3 2021$559,000
+15.3%
95,994
+104.2%
0.01%
+40.0%
Q2 2021$485,000
+54.0%
47,013
+56.8%
0.01%
+25.0%
Q1 2021$315,000
-75.4%
29,982
-65.8%
0.00%
-78.9%
Q3 2020$1,278,000
+43.1%
87,543
+85.7%
0.02%
+26.7%
Q2 2020$893,000
+128.4%
47,153
+131.5%
0.02%
+36.4%
Q1 2020$391,000
-69.4%
20,366
-69.4%
0.01%
-52.2%
Q4 2019$1,277,000
+152.4%
66,600
-21.2%
0.02%
+155.6%
Q2 2019$506,000
+381.9%
84,504
+372.1%
0.01%
+200.0%
Q1 2019$105,000
-69.9%
17,901
-51.9%
0.00%
-81.2%
Q4 2018$349,000
+2.6%
37,230
+86.6%
0.02%
-15.8%
Q3 2018$340,000
+131.3%
19,949
+130.4%
0.02%
+171.4%
Q2 2018$147,000
-56.9%
8,659
-65.9%
0.01%
-65.0%
Q1 2018$341,000
+3688.9%
25,385
+2536.0%
0.02%
Q4 2017$9,0009630.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders